hsa-mir-4659a-3p _LIHC.png
hsa-mir-892b _LIHC.png
hsa-mir-130b-3p _LIHC.png
Expression analysis of TCGA samples
Basic Information
VIS ID
TVIS10020363
Fusion event
HBV-AGO1 integration
Validated
No
Detection method
VirusScan
Data source
Curated
Sample type
Disease
Hepatocellular carcinoma (HCC)
Quality evaluation
Good
Reported year
2016
PubMed ID
Virus Sequence
Virus name
HBV
Reference genome
Start
1181
End
2281
Orient
+
Integrated sequence
GTTTGCTGACGCAACCCCCACGGGTTGGGGCTTGGCCATAGGCCATCGGCGCATGCGTGGAACCTTTGTGGCTCCTCTGCCGATCCATACTGCGGAACTCCTAGCAGCTTGTTTTGCTCGCAGCCGGTCTGGAGCGAAACTTATCGGAACCGACAACTCAGTTGTCCTCTCTCGGAAATACACCTCCTTTCCATGGCTGCTAGGCTGTGCTGCCAACTGGATCCTGCGCGGGACGTCCTTTGTCTACGTCCCGTC
Host Sequence
Chromosome
chr1
Cytoband
p34.3
Reference genome
End
36340120/35874519 (Hg38)
Orient
+
Location type
Intronic
Target gene
miRNAs that regulate target gene
hsa-mir-503-5p ; hsa-mir-148b-3p ; hsa-mir-130b-3p ; hsa-mir-106b-5p ; hsa-mir-107 ; hsa-mir-93-5p ; hsa-mir-19b-3p ; hsa-mir-320c ; hsa-mir-877-3p ; hsa-mir-877-5p ; hsa-mir-744-5p ; hsa-mir-455-3p ; hsa-mir-151a-5p ; hsa-mir-93-3p ; hsa-mir-769-3p ; hsa-mir-421 ; hsa-mir-652-3p ; hsa-mir-628-3p ; hsa-mir-615-3p ; hsa-mir-18a-3p ; hsa-mir-193b-3p ; hsa-mir-146b-5p ; hsa-mir-484 ; hsa-mir-423-3p ; hsa-mir-324-5p ; hsa-mir-326 ; hsa-mir-328-3p ; hsa-mir-330-3p ; hsa-mir-378a-3p ; hsa-mir-320a ; hsa-mir-195-5p ; hsa-mir-194-5p ; hsa-mir-186-5p ; hsa-mir-185-5p ; hsa-mir-149-5p ; hsa-mir-138-5p ; hsa-let-7g-5p ; hsa-mir-212-3p ; hsa-mir-34a-5p ; hsa-mir-30d-5p ; hsa-mir-30c-5p ; hsa-mir-197-3p ; hsa-mir-106a-5p ; hsa-mir-99a-5p ; hsa-mir-92a-3p ; hsa-mir-31-5p ; hsa-mir-29a-3p ; hsa-mir-26a-5p ; hsa-mir-25-3p ; hsa-mir-20a-5p ; hsa-mir-17-5p ; hsa-let-7e-5p ; hsa-let-7c-5p ; hsa-let-7b-5p ; hsa-let-7a-5p ; hsa-mir-3678-3p ; hsa-mir-4779 ; hsa-mir-2467-3p ; hsa-mir-19a-3p ; hsa-mir-20b-5p ; hsa-mir-519d-3p ; hsa-mir-103a-3p ; hsa-let-7d-5p ; hsa-let-7f-5p ; hsa-let-7i-5p ; hsa-mir-1-3p ; hsa-mir-6734-5p ; hsa-mir-1226-5p ; hsa-mir-6834-5p ; hsa-mir-4684-5p ; hsa-mir-4721 ; hsa-mir-3616-3p ; hsa-mir-942-5p ; hsa-mir-1251-5p ; hsa-mir-517-5p ; hsa-mir-325 ; hsa-mir-7843-5p ; hsa-mir-6879-5p ; hsa-mir-4632-5p ; hsa-mir-6735-5p ; hsa-mir-4436b-3p ; hsa-mir-100-3p ; hsa-mir-3166 ; hsa-mir-4756-3p ; hsa-mir-1324 ; hsa-mir-449c-5p ; hsa-mir-34b-5p ; hsa-mir-2682-5p ; hsa-mir-940 ; hsa-mir-6893-5p ; hsa-mir-6808-5p ; hsa-mir-6511a-5p ; hsa-mir-1910-3p ; hsa-mir-8075 ; hsa-mir-219a-2-3p ; hsa-mir-218-5p ; hsa-mir-4266 ; hsa-mir-4717-5p ; hsa-mir-3919 ; hsa-mir-4695-5p ; hsa-mir-6510-5p ; hsa-mir-4690-5p ; hsa-mir-6165 ; hsa-mir-4659b-3p ; hsa-mir-4659a-3p ; hsa-mir-6875-3p ; hsa-mir-4279 ; hsa-mir-4777-3p ; hsa-mir-6511b-3p ; hsa-mir-6511a-3p ; hsa-mir-892b ; hsa-mir-4514 ; hsa-mir-4524b-3p ; hsa-mir-4692
Nearest miRNA
hsa-mir-12136/Upstream/1203775; hsa-mir-101-1/Downstream/1287044;
Upstream sequence
ttatccaaaatcttgtaggacacgttcaaaattgtagacttactccaagagcaatatggagagttttaagcagtgatatgaccAAAGTTCTTAATTCATG
Downstream sequence
tctctccctctccttgggcctccctattccttgagacacaacaatactgaaagtaggccaattaataaccctgcaatggcctgtaagtgttcaagtgaaa
Target sequence
GTGATAGTCCCTCAGTTGTTTTGTTTCATACCAACTCTTGGTTTCATAGCTATAAGCTTTTTACAATAAAGGCAAATTTCCTCTTTCAGTTTCTTGTTGCTCCCTCTGGTCTGTTGAGAGCACTGTGATATAACTTAGGGGTATGACCAATCAGTCTTCCTGATTTTTCAGTCTGTCTTGACAGTTCTCTCAAAAGCCTCTCTTTTCCCGATCAGCTTCACCTCTTCTCTCGTGAAAGAGTACTTTTCCTAGATC
Reference
Cao, S., et al.Divergent viral presentation among human tumors and adjacent normal tissues. Sci Rep,2016, 6: 28294.
Curate